GSK hit with EU Court ruling over ‘pay-for-delay’ drug case
The ruling harks back to the CMA’s 2016 case that found GlaxoSmithKline had agreed to make payments totalling over £50 million to other generic suppliers of paroxetine.
31st January 2020
Latest news
Peanut allergy vaccine shows promise
There are currently no approved immunotherapies for the treatment of peanut allergies.
31st January 2020
New drug candidate created by AI in ‘world first’
The drug, DSP-1181, was created through joint research by both the companies and Centaur Chemist’s AI platform.
30th January 2020
J&J launches ‘multi-pronged’ coronavirus response
Using its AdVac and PER.C6 technologies, the company wants to rapidly upscale production of the optimal vaccine candidate.
30th January 2020
NHS to tackle climate “health emergency” with new campaign
The campaign, dubbed “For a Greener NHS”, will address both the causes of climate change and air pollution.
30th January 2020
New treatment ‘made from sugar’ could help fight viral outbreaks
The team has “successfully engineered a new molecule, which is a modified sugar that shows broad-spectrum antiviral properties.”
30th January 2020
EMA validates Kite’s CAR-T filing
In December last year the company also filed the CAR-T therapy with the FDA.
30th January 2020
Industry leading companies are entering their best and brightest in CROY 2020
The 2020 competition has already seen a large number of top industry companies being represented as we approach the final month of entries.
30th January 2020
European Commission expands use for Janssen’s Erleada
The extension is based on data from the Phase III TITAN study, which assessed the addition of the drug to androgen deprivation therapy in a broad range of patients with metastatic hormone-sensitive prostate cancer.
29th January 2020
Oncimmune test more effective than CT Surveillance in lung cancer
Lung cancer is one of the most prevalent forms of cancer and kills more women than breast and ovarian cancers combined.
29th January 2020
NHS competition to inject £140m in to ‘game changing’ AI
The competition entries are open from Tuesday 28 January for the next five weeks, and companies can bid for a share of £140 million to launch their innovation across the health service.
29th January 2020
Cancer patients facing delays in getting ‘innovative’ drugs
A study found that the most innovative cancer drugs took 3.2 years longer to go from the filing of the patent through to NHS.
29th January 2020
‘Rapid’ NHS response teams to help older people at home
Backed by £14 million of investment, local health service and council teams will begin the roll out of the “Urgent Community Response” teams from April.
28th January 2020
Success for Enhertu in Phase II gastric cancer trial
The drug recently received Accelerated Approval in the US for certain HER2-positive unresectable or metastatic breast cancer.
28th January 2020
Brilinta hits endpoint in late-stage stroke trial
Patients were randomised within 24 hours of onset of acute ischaemic stroke or high-risk transient ischaemic attack symptoms and followed-up for 30 days of treatment.
28th January 2020
